Ventriculo peritoneal shunt for intracranial hypertension in HIV-associated cryptococcus meningitis

张海鹏,崔亚辉,张建民,胡昕,陈海平,张斌海,闫俊,张忠东,师金川,喻剑华
DOI: https://doi.org/10.3877/cma.j.issn.2095-9141.2021.02.009
2021-01-01
Abstract:Objective:To explore the clinical efficacy of ventriculo peritoneal (V-P) shunt for intracranial hypertension in human immunodeficiency virus (HIV)-associated cryptococcus meningitis (CM).Methods:A retrospective analysis was conducted on the data of 59 HIV-associated CM patients in the Second Department of Infection Disease, Affiliated Hangzhou Xixi Hospital, Zhejiang University School of Medicine from May 2015 to April 2019. Among those patients, 10 cases underwent V-P shunt due to intracranial hypertension, meanwhile underwent antifungal therapy including amphotericin B, flucytosine, fluconazole and itraconazole was given according to the guidelines. The intracranial pressure and alleviation of intracranial hypertension symptoms were taken as observation indexes.Results:All patients with shunt were stopped with mannitol, glycerin fructose and other drugs, and the intracranial pressure was lower than 200 mmH2O (1 mmH2O=0.0098 kPa). The headache, vomiting, consciousness disorder, epilepsy, optic papilledema were all improved significantly.Conclusion:Intracranial hypertension in HIV-associated cryptococcus meningitis should be aggressively treated at early time. It might be safety that placing the lumbago cistern drainage tube for 13 d. Intracranial pressure could be efficiently decreased by V-P shunt in early phase, which could also improve the clinical symptoms and reduce the death rate.
What problem does this paper attempt to address?